RWC Asset Management »

Eyepoint Pharmaceuticals shares owned by RWC Asset Management

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by RWC Asset Management from 13F filings

Historical chart of RWC Asset Management investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by RWC Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by RWC Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $315k 17k 18.27
2025-09-30 $231k 16k 14.24

More positions owned by RWC Asset Management

Macy's (M)
Hp (HPQ)
Exelon Corporation (EXC)
Lear Corp Com New (LEA)
Gold Fields Sponsored Adr (GFI)
Sociedad Quimica Y Minera De Spon Adr Ser B (SQM)
Johnson & Johnson (JNJ)
Molson Coors Beverage CL B (TAP)
Omni (OMC)
Grupo Financiero Galicia Sponsored Adr (GGAL)
SYSCO Corporation (SYY)
Paychex (PAYX)
Vista Energy S.a.b. De C.v. Sponsored Ads (VIST)
Keurig Dr Pepper (KDP)
American Tower Reit (AMT)

View all positions for RWC Asset Management

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Suvretta Capital Management
BlackRock
Federated Investors
Adage Capital Partners GP
Franklin Resources
Vanguard Group
Paradigm Biocapital Advisors
TCG Crossover Management
OrbiMed Advisors
Citadel Advisors
Geode Capital Management
State Street Corporation
Standard Life Aberdeen
Goldman Sachs Group

View all funds holding Eyepoint Pharmaceuticals